Defence Therapeutics Inc. (OTCMKTS:DTCFF – Get Free Report)’s share price traded down 15% during trading on Monday. The stock traded as low as $0.2210 and last traded at $0.2210. 10,105 shares changed hands during mid-day trading, an increase of 8% from the average daily volume of 9,363 shares. The stock had previously closed at $0.26.
Defence Therapeutics Price Performance
The company has a 50-day simple moving average of $0.31 and a 200 day simple moving average of $0.36.
About Defence Therapeutics
Featured Articles
- Five stocks we like better than Defence Therapeutics
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Defence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Defence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
